From January 2024 to July 2024, the Federation of American Scientists interviewed 30 current and former FDA Advisory Committee (AdComm) members to learn about the Advisory Committee experience and identify existing challenges and opportunities to help inform actionable policy solutions. The goal of this project was to create a vision for how the FDA and other federal agencies can better engage external scientific experts and the public to address critical challenges facing public health. Discussions included topics such as how the FDA can better leverage Advisory Committee membership through expanding the role of the chair, overall committee composition, implementing mandatory training programs, streamlining the conflict of interest process, and more.
Based on these discussions, we were able to source potential policy recommendations that may assist with enhancing the FDA’s ability to obtain valuable advice for evidence-based decision-making. The results of these discussions are presented in case studies detailing the recurring themes that emerged and policy recommendations for improvement.
FACA Toolkit
Final Report
Protecting the health and safety of the American public and ensuring that the public has the opportunity to participate in the federal decision-making process is crucial. As currently organized, FACs are not equipped to provide the best evidence-based advice.
These recommendations can catapult the Advisory Committee structure into one that continues providing the government with the best advice.
Improving public awareness of FDA Advisory Committees would improve public trust and deter misinformation related to the approval of medical products.
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.
Despite significant political momentum behind reform efforts, limited attention has been paid to the federal workforce that will actually be responsible for interpreting and implementing new permitting regulations and better outcomes.
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States federal government invests nearly $150 billion annually in research and development. However, the supporting evidence generates wildly different estimates depending on the methods and available data.
The digital government field has an opportunity to build a more responsive and resilient government by pushing into new frontiers, with new tools, approaches, and even organizations that don’t exist yet. This is the time for radical experimentation, delivery, and exploration.